Biopharma company for cancer medicine
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 20, 2020 | Series B | $25M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Yinglian Health Fund | — | Series B |